283 related articles for article (PubMed ID: 29667116)
1. Intraoperative Pancreatic Cancer Detection using Tumor-Specific Multimodality Molecular Imaging.
Tummers WS; Miller SE; Teraphongphom NT; Gomez A; Steinberg I; Huland DM; Hong S; Kothapalli SR; Hasan A; Ertsey R; Bonsing BA; Vahrmeijer AL; Swijnenburg RJ; Longacre TA; Fisher GA; Gambhir SS; Poultsides GA; Rosenthal EL
Ann Surg Oncol; 2018 Jul; 25(7):1880-1888. PubMed ID: 29667116
[TBL] [Abstract][Full Text] [Related]
2. Detection of visually occult metastatic lymph nodes using molecularly targeted fluorescent imaging during surgical resection of pancreatic cancer.
Tummers WS; Miller SE; Teraphongphom NT; van den Berg NS; Hasan A; Longacre TA; Fisher GA; Bonsing BA; Vahrmeijer AL; Gambhir SS; Swijnenburg RJ; Rosenthal EL; Poultsides GA
HPB (Oxford); 2019 Jul; 21(7):883-890. PubMed ID: 30723062
[TBL] [Abstract][Full Text] [Related]
3. Preclinical evaluation of near-infrared (NIR) fluorescently labeled cetuximab as a potential tool for fluorescence-guided surgery.
Saccomano M; Dullin C; Alves F; Napp J
Int J Cancer; 2016 Nov; 139(10):2277-89. PubMed ID: 27428782
[TBL] [Abstract][Full Text] [Related]
4. Preclinical Evaluation of a Humanized, Near-Infrared Fluorescent Antibody for Fluorescence-Guided Surgery of MUC16-Expressing Pancreatic Cancer.
Olson MT; Aguilar EN; Brooks CL; Isder CC; Muilenburg KM; Talmon GA; Ly QP; Carlson MA; Hollingsworth MA; Mohs AM
Mol Pharm; 2022 Oct; 19(10):3586-3599. PubMed ID: 35640060
[TBL] [Abstract][Full Text] [Related]
5. Fluorescence- and multispectral optoacoustic imaging for an optimized detection of deeply located tumors in an orthotopic mouse model of pancreatic carcinoma.
Napp J; Stammes MA; Claussen J; Prevoo HAJM; Sier CFM; Hoeben FJM; Robillard MS; Vahrmeijer AL; Devling T; Chan AB; de Geus-Oei LF; Alves F
Int J Cancer; 2018 May; 142(10):2118-2129. PubMed ID: 29277891
[TBL] [Abstract][Full Text] [Related]
6. Intraoperative Molecular Fluorescence Imaging of Pancreatic Cancer by Targeting Vascular Endothelial Growth Factor: A Multicenter Feasibility Dose-Escalation Study.
Mulder BGS; Koller M; Duiker EW; Sarasqueta AF; Burggraaf J; Meijer VE; Vahrmeijer AL; Hoogwater FJH; Bonsing BA; van Dam GM; Mieog JSD; Pranger BK
J Nucl Med; 2023 Jan; 64(1):82-89. PubMed ID: 35680414
[TBL] [Abstract][Full Text] [Related]
7. Image-Guided Surgery in Patients with Pancreatic Cancer: First Results of a Clinical Trial Using SGM-101, a Novel Carcinoembryonic Antigen-Targeting, Near-Infrared Fluorescent Agent.
Hoogstins CES; Boogerd LSF; Sibinga Mulder BG; Mieog JSD; Swijnenburg RJ; van de Velde CJH; Farina Sarasqueta A; Bonsing BA; Framery B; Pèlegrin A; Gutowski M; Cailler F; Burggraaf J; Vahrmeijer AL
Ann Surg Oncol; 2018 Oct; 25(11):3350-3357. PubMed ID: 30051369
[TBL] [Abstract][Full Text] [Related]
8. First-in-human intraoperative near-infrared fluorescence imaging of glioblastoma using cetuximab-IRDye800.
Miller SE; Tummers WS; Teraphongphom N; van den Berg NS; Hasan A; Ertsey RD; Nagpal S; Recht LD; Plowey ED; Vogel H; Harsh GR; Grant GA; Li GH; Rosenthal EL
J Neurooncol; 2018 Aug; 139(1):135-143. PubMed ID: 29623552
[TBL] [Abstract][Full Text] [Related]
9. Advances in Diagnostic and Intraoperative Molecular Imaging of Pancreatic Cancer.
Tummers WS; Willmann JK; Bonsing BA; Vahrmeijer AL; Gambhir SS; Swijnenburg RJ
Pancreas; 2018 Jul; 47(6):675-689. PubMed ID: 29894417
[TBL] [Abstract][Full Text] [Related]
10. Tumour-specific fluorescence-guided surgery for pancreatic cancer using panitumumab-IRDye800CW: a phase 1 single-centre, open-label, single-arm, dose-escalation study.
Lu G; van den Berg NS; Martin BA; Nishio N; Hart ZP; van Keulen S; Fakurnejad S; Chirita SU; Raymundo RC; Yi G; Zhou Q; Fisher GA; Rosenthal EL; Poultsides GA
Lancet Gastroenterol Hepatol; 2020 Aug; 5(8):753-764. PubMed ID: 32416764
[TBL] [Abstract][Full Text] [Related]
11. Recent development of a magneto-optical nanoplatform for multimodality imaging of pancreatic ductal adenocarcinoma.
Zhang X; Zeng Z; Liu H; Xu L; Sun X; Xu J; Song G
Nanoscale; 2022 Mar; 14(9):3306-3323. PubMed ID: 35170601
[TBL] [Abstract][Full Text] [Related]
12. Surgery after FOLFIRINOX treatment for locally advanced and borderline resectable pancreatic cancer: increase in tumour attenuation on CT correlates with R0 resection.
Marchegiani G; Todaro V; Boninsegna E; Negrelli R; Sureka B; Bonamini D; Salvia R; Manfredi R; Pozzi Mucelli R; Bassi C
Eur Radiol; 2018 Oct; 28(10):4265-4273. PubMed ID: 29679211
[TBL] [Abstract][Full Text] [Related]
13. Development and Preclinical Validation of a Cysteine Knottin Peptide Targeting Integrin αvβ6 for Near-infrared Fluorescent-guided Surgery in Pancreatic Cancer.
Tummers WS; Kimura RH; Abou-Elkacem L; Beinat C; Vahrmeijer AL; Swijnenburg RJ; Willmann JK; Gambhir SS
Clin Cancer Res; 2018 Apr; 24(7):1667-1676. PubMed ID: 29298796
[No Abstract] [Full Text] [Related]
14. Staging of pancreatic cancer: resectable, borderline resectable, and unresectable disease.
Soloff EV; Zaheer A; Meier J; Zins M; Tamm EP
Abdom Radiol (NY); 2018 Feb; 43(2):301-313. PubMed ID: 29198002
[TBL] [Abstract][Full Text] [Related]
15. Optical magnetic multimodality imaging of plectin-1-targeted imaging agent for the precise detection of orthotopic pancreatic ductal adenocarcinoma in mice.
Zhang W; Liang X; Zhu L; Zhang X; Jin Z; Du Y; Tian J; Xue H
EBioMedicine; 2022 Jun; 80():104040. PubMed ID: 35525203
[TBL] [Abstract][Full Text] [Related]
16. Intraoperative Near-infrared Imaging Can Identify Neoplasms and Aid in Real-time Margin Assessment During Pancreatic Resection.
Newton AD; Predina JD; Shin MH; Frenzel-Sulyok LG; Vollmer CM; Drebin JA; Singhal S; Lee MK
Ann Surg; 2019 Jul; 270(1):12-20. PubMed ID: 31188797
[TBL] [Abstract][Full Text] [Related]
17. Near-Infrared Fluorescence Imaging of Pancreatic Cancer Using a Fluorescently Labelled Anti-CEA Nanobody Probe: A Preclinical Study.
van Manen L; de Muynck LDAN; Baart VM; Bhairosingh S; Debie P; Vahrmeijer AL; Hernot S; Mieog JSD
Biomolecules; 2023 Mar; 13(4):. PubMed ID: 37189366
[TBL] [Abstract][Full Text] [Related]
18. Intraoperative detection of colorectal and pancreatic liver metastases using SGM-101, a fluorescent antibody targeting CEA.
Meijer RPJ; de Valk KS; Deken MM; Boogerd LSF; Hoogstins CES; Bhairosingh SS; Swijnenburg RJ; Bonsing BA; Framery B; Fariña Sarasqueta A; Putter H; Hilling DE; Burggraaf J; Cailler F; Mieog JSD; Vahrmeijer AL
Eur J Surg Oncol; 2021 Mar; 47(3 Pt B):667-673. PubMed ID: 33158638
[TBL] [Abstract][Full Text] [Related]
19. Optimizing Preoperative Strategies for Occult Metastasis Detection in PDAC: Integrating Multimodal Imaging and Pathological Correlation for Improved Patient Outcomes.
Kahraman G; Arslan-Kahraman DI
Acad Radiol; 2024 May; 31(5):2188. PubMed ID: 38290890
[No Abstract] [Full Text] [Related]
20. A thiopyrylium salt for PET/NIR-II tumor imaging and image-guided surgery.
Zhang X; Ding B; Qu C; Li H; Sun Y; Gai Y; Chen H; Fang H; Qian K; Zhang Y; Cheng Z; Lan X
Mol Oncol; 2020 May; 14(5):1089-1100. PubMed ID: 32191387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
